Experiments in mice may help boost newly FDA-approved therapy for spinal muscular atrophy

Academic and drug industry investigators say they have identified a new biological target for treating spinal muscular atrophy.

Source: ScienceDaily Headlines - January 9, 2017 Category: Science Source Type: news